← Leaderboards
Albert J. Auguste
Virginia Polytechnic Inst And St Univ
$2,632,739
Attributed
$3,006,679
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $665.9K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,006,679 · 4
By mechanism
R01$1,992,922 · 1
R21$468,636 · 1
T32$279,245 · 1
K22$265,876 · 1
Top collaborators
- Jesse Hong-Sae Erasmus2 shared
- Edward J Smith1 shared
Others in their field
Other Emerging Leaders on “Medical”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$96,732,394
- Klaus Romero · Critical Path Institute$88,602,036
Research focus
MedicalIn VivoZika VirusVirusIn VitroPreventVaccinesVirus ReplicationMortalityImmune ResponseTransmission ProcessMorbidity - Disease RateArbovirusesInnovationLongevityProtective EfficacyImmunityImmunizationMouse ModelPathogenGeographyEventCombatDose
Grant awards (10)
Virginia Tech Initiative to Maximize Student Development$279,245
T32 · FY2025 · GM · contact PI
A Novel Strategy for Generating Safe and Effective Flavivirus Vaccines$390,087
R01 · FY2024 · AI · contact PI
Pre-clinical evaluation of alpha-Cache; a novel RNA vaccine for an emerging orthobunyavirus$206,342
R21 · FY2024 · AI · contact PI
A Novel Strategy for Generating Safe and Effective Flavivirus Vaccines$403,588
R01 · FY2023 · AI · contact PI
Pre-clinical evaluation of alpha-Cache; a novel RNA vaccine for an emerging orthobunyavirus$262,294
R21 · FY2023 · AI · contact PI
A Novel Strategy for Generating Safe and Effective Flavivirus Vaccines$416,856
R01 · FY2022 · AI · contact PI
A Novel Strategy for Generating Safe and Effective Flavivirus Vaccines$395,583
R01 · FY2021 · AI · contact PI
A Novel Strategy for Generating Safe and Effective Flavivirus Vaccines$386,808
R01 · FY2020 · AI · contact PI
Mechanisms by which insect specific flaviviruses are host restricted and preclude super-infection with pathogenic flaviviruses$105,926
K22 · FY2019 · AI · contact PI
Mechanisms by which insect specific flaviviruses are host restricted and preclude super-infection with pathogenic flaviviruses$159,950
K22 · FY2018 · AI · contact PI